Introduction: Currently, promising outcomes from clinical trials of allogeneic cells, especially
allogeneic mesenchymal stromal cells, fibroblasts, keratinocytes, and human cardiac stem …

Cell therapy is poised to play an enormous role in regenerative medicine. However, little
guidance is being made available to academic and industrial entities in the start-up phase …

Although cell therapies continue to reshape multiple therapeutics areas, the field is still
grappling with how to best manufacture therapies. Allogeneic therapies are currently …

Allogeneic cell therapy products are generating encouraging clinical and pre-clinical results.
Pluripotent stem cell (PSC) derived therapies, in particular, have substantial momentum and …

Incomes currently generated by the global cell therapy market are estimated to be~ US $400
million. That value represents 10 main products, some of which have been on the market …

As cell therapy processes mature from benchtop research protocols to industrial processes
capable of manufacturing market-relevant numbers of doses, new cell manufacturing …

The field of cell-based therapies is evolving quickly, and its potential for transformational
new treatment modalities has generated great excitement in the scientific community. In the …

Background: A novel manufacturing industry is emerging to translate unique cellular therapy
bioprocesses to robust, scaled manufacturing production for successful clinical translation …

Stem cell therapies represent a significant opportunity, with the potential to provide global
health and wealth benefits. The scalable manufacture of stem cell therapies will be …

One of the biggest challenges for the commercialization of stem cell therapies (SCTs) is
securing the therapeutic potential of the cells. This requires cellular preservation to be …